AZT.OL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 27727 min ago

@ Kr.25.90

Wydano: 30 bal. 2024 @ 17:25

Zwrot: -9.27%

Poprzedni sygnał: bal. 30 - 17:25

Poprzedni sygnał: Sprzedaż

Zwrot: 0.00 %

Live Chart Being Loaded With Signals

Commentary (16 geg. 2024 @ 17:25):

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing...

Stats
Dzisiejszy wolumen	16 518.00
Średni wolumen	31 205.00
Kapitalizacja rynkowa	1.20B
EPS	Kr.0 ( 2024-05-07 )
Last Dividend	Kr.0 ( N/A )
Next Dividend	Kr.0 ( N/A )
P/E	69.12
ATR14	Kr.0.137 (0.59%)

Arcticzymes Technologies Korelacja

10 Najbardziej pozytywne korelacje
IOX.OL	0.921
ELIMP.OL	0.91
PRS.OL	0.875
HEX.OL	0.862
PLT.OL	0.854
HBC.OL	0.844
ACC.OL	0.842
ARGEO.OL	0.834

10 Najbardziej negatywne korelacje
SVEG.OL	-0.917
PROT.OL	-0.913
AGLX.OL	-0.881
BRG.OL	-0.874
KOG.OL	-0.874
2020.OL	-0.868
SNI.OL	-0.863
SOGN.OL	-0.86
GOGL.OL	-0.859
FRO.OL	-0.857

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Arcticzymes Technologies Finanse

Annual	2023
Przychody:	Kr.118.94M
Zysk brutto:	Kr.39.57M (33.27 %)
EPS:	Kr.0.380

FY	2023
Przychody:	Kr.118.94M
Zysk brutto:	Kr.39.57M (33.27 %)
EPS:	Kr.0.380

FY	2022
Przychody:	Kr.136.97M
Zysk brutto:	Kr.131.79M (96.22 %)
EPS:	Kr.0.650

FY	2021
Przychody:	Kr.127.97M
Zysk brutto:	Kr.124.09M (96.96 %)
EPS:	Kr.0.940

Financial Reports:

No articles found.

Arcticzymes Technologies Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Arcticzymes Technologies

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining DNA /RNA fragments. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway.